Why I’m Excited About Aducanumab (Aduhelm)!
In this episode of Evolving Past Alzheimer’s, Dr. Nate Bergman quickly summarizes the story up the FDA’s recent “accelerated approval” of Biogen’s
In this episode of Evolving Past Alzheimer’s, Dr. Nate Bergman quickly summarizes the story up the FDA’s recent “accelerated approval” of Biogen’s
In this episode of Evolving Past Alzheimer’s, Dr. Nate Bergman speaks with Dr. Marwan Sabbagh, clinical and research leader at the Cleveland
For the first time in our lifetime, we are seeing research and results that give us hope in the fight to prevent and treat cognitive decline. The key is knowing and getting ahead of it early!
It's been 18 years since the last drug was approved for Alzheimer's, but on Monday, June 7, 2021, the FDA gave "Accelerated